IN8BIO, INC. (INAB) [Rocket]

In millions, except per share items	Jun-30-23	Jun-05-23	Mar-31-23	Mar-05-23	Sep-30-22	Jun-30-22	Jun-05-22	Mar-31-22
	10-Q	8-K	10-Q	8-K	8-K/A	10-Q	8-K	10-Q
Revenues	0.0	4.1	0.0	4.4	4.3	0.0	3.5	0.0
Revenue growth		18.0%		84.2%
Cost of goods sold	0.0	7.7	0.0	8.4	7.4	0.0	7.2	0.0
Gross profit	0.0	-3.6	0.0	-4.1	-3.1	0.0	-3.7	0.0
Gross margin		-86.6%		-92.5%	-73.9%		-104.9%
Selling, general and administrative [+]	7.7	3.6	7.9	3.5	3.1	7.2	3.7	6.1
General and administrative		3.6		3.5	3.1		3.7
Other selling, general and administrative
Other operating expenses	-7.7	0.6	-7.9		1.1	-7.2	-0.2	-6.1
EBIT [+]	0.0	-7.7	0.0	-7.5	-7.4	0.0	-7.2	0.0
EBIT growth		7.5%		22.5%
EBIT margin		-186.6%		-171.6%	-173.9%		-204.9%
Other income (expense), net	-7.7		-7.5	7.5		-7.2		-6.1
Pre-tax income	-7.7	-7.7	-7.5	0.0	-7.4	-7.2	-7.2	-6.1
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%		0.0%	0.0%	0.0%	0.0%
Net income	-7.7	-7.7	-7.5	0.0	0.0	-7.2	-7.2	-6.1
Net margin		-186.6%		0.0%	-0.2%		-204.9%

Basic EPS [+]	($0.27)	$0.00	($0.30)	$0.00	($0.34)	($0.38)	$0.00	($0.33)
Growth	-28.9%	-28.9%	-6.9%		34.8%	-52.9%		-47.9%
Diluted EPS [+]	($0.27)	$0.00	($0.30)	$0.00	($0.34)	($0.38)	$0.00	($0.33)
Growth	-28.9%	-28.9%	-6.9%		34.8%	-52.9%		-47.9%

Shares outstanding (basic) [+]	28.5	28,472.3	24.7	24,732.6	0.0	18.8	18,828.7	18.8
Growth	51.2%	51.2%	31.6%	31.6%	-99.8%	400.2%		399.4%
Shares outstanding (diluted) [+]	28.5	28,472.3	24.7	24,732.6	0.0	18.8	18,828.7	18.8
Growth	51.2%	51.2%	31.6%	31.6%	-99.8%	400.2%		399.4%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.